Nothing Special   »   [go: up one dir, main page]

Stewart et al., 2020 - Google Patents

Perspective: Nanoparticle-Mediated Delivery of Cryoprotectants For Cryopreservation

Stewart et al., 2020

View HTML
Document ID
10488591235122820850
Author
Stewart S
Arminan A
He X
Publication year
Publication venue
CryoLetters

External Links

Snippet

Nanotechnology research has continued to garner interest and is investigated across a number of fields and industries, ranging from water treatment to clinical and biomedical applications. In biomedical research, for example, polymeric nanoparticles can be leveraged …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02Preservation of living parts
    • A01N1/0205Chemical aspects
    • A01N1/021Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/30Macromolecular compounds
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
JP6978644B2 (en) Antifreeze agents, antifreeze and cryopreservation compositions, their use and cryopreservation methods
Ma et al. Advanced biomaterials in cell preservation: Hypothermic preservation and cryopreservation
CN106538512B (en) A kind of active stem cell gel preparation of holding freeze-stored cell and its application
CN108207930B (en) Cocktail type cryoprotectant and application thereof
Liu et al. Dual suppression effect of magnetic induction heating and microencapsulation on ice crystallization enables low-cryoprotectant vitrification of stem cell–alginate hydrogel constructs
Cheng et al. Cold‐responsive nanocapsules enable the sole‐cryoprotectant‐trehalose cryopreservation of β cell–laden hydrogels for diabetes treatment
Karow Jr Cryoprotectants–a new class of drugs
CA2745539C (en) Cellular compositions for use in therapy
Stolzing et al. Hydroxyethylstarch in cryopreservation–Mechanisms, benefits and problems
CN103037847B (en) For the preparation of the method for dry, stable hemostatic composition
JP2009247276A (en) Thawed organ or tissue or thawed cell group to be donated, transplanted, added, or administered to living body, method for producing the same, and supercooled solution used therefor, and production apparatus for the same
CN102917691A (en) Process for making dry and stable hemostatic compositions
Stewart et al. Perspective: Nanoparticle-Mediated Delivery of Cryoprotectants For Cryopreservation
FR3038324A1 (en) METHOD FOR CRYOPRESERVATION OF THERAPEUTICALLY TARGED CELLS
Yao et al. Nanoparticle‐mediated intracellular protection of natural killer cells avoids cryoinjury and retains potent antitumor functions
Yao et al. Cryopreservation of NK and T cells without DMSO for adoptive cell-based immunotherapy
Huang et al. Advanced nanomaterials-assisted cell cryopreservation: a mini review
Xu et al. Hydrogel-based cardiac repair and regeneration function in the treatment of myocardial infarction
CN109232995A (en) The temperature-sensitive hydrogel of adjustable response temperature contains cell material and the preparation method and application thereof
Crowe et al. Stabilization of cells during freeze-drying: the trehalose myth
Liu et al. An autophagy-inhibitory MOF nanoreactor for tumor-targeted synergistic therapy
CN115005199A (en) Cryopreservation solution and cryopreservation method for natural killer cells and application of cryopreservation solution and cryopreservation method
Matsumura et al. 7 Cell and Materials Interface in Cryobiology and Cryoprotection
Kim et al. Cryopreservation of engineered tissues and organoids
FR3038325A1 (en) METHOD FOR CRYOPRESERVATION OF THERAPEUTICALLY TARGED CELLS